中国现代药物应用
中國現代藥物應用
중국현대약물응용
CHINESE JOURNAL OF MODERN DRUG APPLICATION
2014年
23期
7-8
,共2页
丁苯酞%依达拉奉%急性进展性脑梗死
丁苯酞%依達拉奉%急性進展性腦梗死
정분태%의체랍봉%급성진전성뇌경사
Butylphthalide%Edaravone%Acute progressive cerebral infarction
目的:研究丁苯酞联合依达拉奉治疗急性进展性脑梗死的治疗效果。方法急性进展性脑梗死患者146例,随机的分成应用依达拉奉治疗的对照组和应用丁苯酞联合依达拉奉治疗的观察组,各73例,治疗周期14 d,比较两组患者治疗后总有效率和日常生活能力评分的变化。结果对照组患者治疗后总有效率为31.5%,观察组患者治疗后总有效率为72.6%,两组比较差异具有统计学意义(P<0.05)。对照组患者治疗后日常生活能力评分为(58.87±25.36)分、观察组患者治疗后日常生活能力评分为(69.14±26.87)分,两组比较差异具有统计学意义(P<0.05)。结论丁苯酞联合依达拉奉治疗急性进展性脑梗死临床治疗效果显著、能够有效的改善神经功能、提高患者自理能力、促进患者的恢复、值得在临床推广应用。
目的:研究丁苯酞聯閤依達拉奉治療急性進展性腦梗死的治療效果。方法急性進展性腦梗死患者146例,隨機的分成應用依達拉奉治療的對照組和應用丁苯酞聯閤依達拉奉治療的觀察組,各73例,治療週期14 d,比較兩組患者治療後總有效率和日常生活能力評分的變化。結果對照組患者治療後總有效率為31.5%,觀察組患者治療後總有效率為72.6%,兩組比較差異具有統計學意義(P<0.05)。對照組患者治療後日常生活能力評分為(58.87±25.36)分、觀察組患者治療後日常生活能力評分為(69.14±26.87)分,兩組比較差異具有統計學意義(P<0.05)。結論丁苯酞聯閤依達拉奉治療急性進展性腦梗死臨床治療效果顯著、能夠有效的改善神經功能、提高患者自理能力、促進患者的恢複、值得在臨床推廣應用。
목적:연구정분태연합의체랍봉치료급성진전성뇌경사적치료효과。방법급성진전성뇌경사환자146례,수궤적분성응용의체랍봉치료적대조조화응용정분태연합의체랍봉치료적관찰조,각73례,치료주기14 d,비교량조환자치료후총유효솔화일상생활능력평분적변화。결과대조조환자치료후총유효솔위31.5%,관찰조환자치료후총유효솔위72.6%,량조비교차이구유통계학의의(P<0.05)。대조조환자치료후일상생활능력평분위(58.87±25.36)분、관찰조환자치료후일상생활능력평분위(69.14±26.87)분,량조비교차이구유통계학의의(P<0.05)。결론정분태연합의체랍봉치료급성진전성뇌경사림상치료효과현저、능구유효적개선신경공능、제고환자자리능력、촉진환자적회복、치득재림상추엄응용。
Objective To research the curative effect of butylphthalide combined with edaravone in treatment of acute progressive cerebral infarction. Methods A total of 146 patients with acute progressive cerebral infarction were randomly divided into control group (treated by edaravone) and observation group (treated by butylphthalide combined with edaravone), and each group contained 73 cases. The treatment period lasted for 14 d. The comparisons were made on the total effective rate and change of activities of daily living (ADL) score between the two groups. Results After the treatment, the total effective rate of the control group was 31.5%, and that of the observation group was 72.6%. The difference between the two groups had statistical significance (P<0.05). The ADL score of the control group after treatment was (58.87±25.36) points, and that of the observation group was (69.14±26.87) points. The difference was statistically significant (P<0.05). Conclusion The combined therapy of butylphthalide and edaravone has precisely curative effect in treating acute progressive cerebral infarction. It can effectively improve the nerve function and self-care ability in patients, and promote their rehabilitation. It is worthy of clinical promotion and application.